4//SEC Filing
Lydon Nicholas 4
Accession 0001179110-21-006414
CIK 0001597264other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 4:14 PM ET
Size
7.1 KB
Accession
0001179110-21-006414
Insider Transaction Report
Form 4
Lydon Nicholas
Director
Transactions
- Award
Common Stock
2021-06-02+2,250→ 39,675 total - Award
Stock Option (Right to Buy)
2021-06-02+4,500→ 4,500 totalExercise: $87.13Exp: 2031-06-02→ Common Stock (4,500 underlying)
Footnotes (2)
- [F1]The reported transaction involved the Reporting Person's receipt of a grant of restricted stock units. The restricted stock units vest with respect to 100% of the shares underlying the restricted stock units on the earlier of (i) the next annual meeting of the Issuer's stockholders and (ii) June 2, 2022. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]This option vests with respect to 100% of the shares underlying the option on the earlier of (i) the next annual meeting of the Issuer's stockholders and (ii) June 2, 2022.
Documents
Issuer
Blueprint Medicines Corp
CIK 0001597264
Entity typeother
Related Parties
1- filerCIK 0001639935
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 4:14 PM ET
- Size
- 7.1 KB